Fuhrman Alan
Known title: Chief Financial OfficerCIK: 0001303521
Fuhrman Alan's purchase track record
Fuhrman Alan has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/30/2024 | TYRA | $152K | -8.3% | -35.5% | -4.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TYRA | ▲ Buy | Grant | 951 | $9K | 9/15/2026 | View on chart |
| TYRA | ▲ Buy | Grant | 20,000 | $0 | 5/5/2026 | View on chart |
| TYRA | ▲ Buy | Grant | 1,376 | $13K | 3/13/2026 | View on chart |
| TYRA | ▲ Buy | Grant | 701 | $6K | 9/15/2025 | View on chart |
| TYRA | ▲ Buy | Grant | 1,238 | $12K | 3/14/2025 | View on chart |
| TYRA | ▲ Buy | Open Market | 9,500 | $152K | 10/30/2024 | View on chart |
| TYRA | ▲ Buy | Grant | 954 | $12K | 9/13/2024 | View on chart |
| TYRA | ▲ Buy | Grant | 932 | $12K | 3/15/2024 | View on chart |
| TYRA | ▲ Buy | Grant | 1,463 | $18K | 9/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Tyra Biosciences (TYRA) Faces Turnaround After 27% Drop
Tyra Biosciences stock has fallen 27% over the past four weeks, a decline that has pushed the price near key support levels. Some market observers suggest this drop may signal a potential turnaround for the company. The average analyst target price remains significantly higher than the current trading range, reflecting a gap between current sentiment and long-term expectations.
Tyra Biosciences (TYRA) Faces Turnaround After 27% Drop. Tyra Biosciences stock has fallen 27% over the past four weeks, a decline that has pushed the price near key support levels. Some market observers suggest this drop may signal a potential turnaround for the company. The average analyst target price remains significantly higher than the current trading range, reflecting a gap between current sentiment and long-term expectations.